LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

AZN

81.26

-0.34%↓

Search

AmerisourceBergen Corporation

Закрыт

СекторЗдравоохранение

0

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

Макс.

Ключевые показатели

By Trading Economics

Доход

-28M

690M

Продажи

5.2B

81B

P/E

Средняя по отрасли

29.939

35.733

Прибыль на акцию

4

Дивидендная доходность

0.75

Рентабельность продаж

0.855

Сотрудники

51,000

EBITDA

-56M

1.3B

Рекомендации

By TipRanks

Рекомендации

Активная покупка

Прогноз на 12 месяцев

+12.6% upside

Дивиденды

By Dow Jones

Дивидендная доходность

Средняя по отрасли

0.75%

3.13%

Дата следующей выплаты дивидендов

28 нояб. 2025 г.

Следующая эксдивидендная дата

14 нояб. 2025 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

-377M

57B

Предыдущая цена открытия

0

Предыдущая цена закрытия

0

Новостные настроения

By Acuity

50%

50%

156 / 371 Рейтинг в Healthcare

AmerisourceBergen Corporation График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

9 сент. 2025 г., 23:37 UTC

Популярные акции

Stocks to Watch: Oracle, Wearable Devices, GameStop

9 сент. 2025 г., 20:41 UTC

Отчет

Oracle's Backlog Surges With Major Customer Deals in 1Q

9 сент. 2025 г., 20:30 UTC

Отчет

GameStop 2Q Sales, Profit Rise

9 сент. 2025 г., 23:19 UTC

Обсуждения рынка

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

9 сент. 2025 г., 21:35 UTC

Отчет

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

9 сент. 2025 г., 21:32 UTC

Отчет

Oracle's Backlog Swells With Big Customer Deals -- Update

9 сент. 2025 г., 21:02 UTC

Приобретения, слияния, поглощения

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

9 сент. 2025 г., 20:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

9 сент. 2025 г., 20:33 UTC

Отчет

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

9 сент. 2025 г., 20:26 UTC

Отчет

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 сент. 2025 г., 20:23 UTC

Отчет

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

9 сент. 2025 г., 20:12 UTC

Отчет

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

9 сент. 2025 г., 20:10 UTC

Отчет

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

9 сент. 2025 г., 20:10 UTC

Отчет

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

9 сент. 2025 г., 20:09 UTC

Отчет

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

9 сент. 2025 г., 20:09 UTC

Отчет

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

9 сент. 2025 г., 20:08 UTC

Отчет

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

9 сент. 2025 г., 20:08 UTC

Отчет

Oracle 1Q Operating Income Was $4.3 B >ORCL

9 сент. 2025 г., 20:08 UTC

Отчет

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

9 сент. 2025 г., 20:08 UTC

Отчет

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

9 сент. 2025 г., 20:07 UTC

Отчет

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

9 сент. 2025 г., 20:06 UTC

Отчет

Oracle 1Q Software Revenue $5.72B >ORCL

9 сент. 2025 г., 20:06 UTC

Отчет

Synopsys 3Q Adj EPS $3.39 >SNPS

9 сент. 2025 г., 20:06 UTC

Отчет

Oracle 1Q Cloud Revenue $7.19B >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Rev $14.93B >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q EPS $1.01 >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Synopsys 3Q EPS $1.50 >SNPS

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Services Revenue $1.35B >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Adj EPS $1.47 >ORCL

9 сент. 2025 г., 20:05 UTC

Отчет

Oracle 1Q Hardware Revenue $670M >ORCL

Сравнение c конкурентами

Изменение цены

AmerisourceBergen Corporation Прогноз

Целевая цена

By TipRanks

12.6% рост

Прогноз на 12 месяцев

Средняя 335.38 USD  12.6%

Максимум 354 USD

Минимум 300 USD

Основано на мнении 8 аналитиков Wall Street, спрогнозировавших целевые цены для AmerisourceBergen Corporation на следующие 12 месяцев – Данные за последние 3 месяца.

Консенсус по рейтингу

By TipRanks

Активная покупка

8 ratings

6

Покупка

2

Удержание

0

Продажа

Настроения

By Acuity

156 / 371Рейтинг в Здравоохранение

Новостные настроения

Neutral

Волатильность

Ниже среднего

Объем новостей (RCV)

Средняя

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании AmerisourceBergen Corporation

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and other services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and offers other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment provides international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals; and offers specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was founded in 1871 and is headquartered in Conshohocken, Pennsylvania.
help-icon Live chat